Back to MORGAN STANLEY MORGAN STANLEY

PRLDPRLD
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in PRELUDE THERAPEUTICS INC

MORGAN STANLEY holds 503,860 shares of PRLD (PRELUDE THERAPEUTICS INC), worth $2.7M as of 2026-Q2. The position was increased (+56.4% shares). PRLD represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$2.7M

Current Shares

503,860

Total Value Change

+$1.6M

Total Shares Change

+216,506

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
503,860
+56.4%
$2.7M0.0%$5.33
37
2026-Q1
Decreased
322,161
-3.8%
$1.1M0.0%$2.63
0
2025-Q4
Increased
334,916
+17.8%
$971,2570.0%$2.84
29
2025-Q3
Decreased
284,203
-0.1%
$409,2520.0%$1.37
0
2025-Q2
Decreased
284,382
-6.1%
$230,1790.0%$0.79
0
2025-Q1
Decreased
302,779
-17.1%
$232,5350.0%$0.80
0
2024-Q4
Increased
365,159
+12.8%
$465,5780.0%$1.21
18
2024-Q3
Increased
323,689
+12.6%
$670,0360.0%$2.12
19
2024-Q2
First report
287,354
-
$1.1M0.0%$3.81
0

Other major holders of PRLD: BAKER BROS. ADVISORS LP, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used